Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Helping physicians complete new training for DEA compliance in opioid prescribing

Another Minimum Wage Increase on the Horizon for Federal Contractors

A look at civil rights cases to be heard by the Supreme Court this term

BakerHostetler attorneys plan, present at NYSBA International Section global conference

<figure class="wp-block-image alignright size-large is-resized"><img decoding="async" loading="lazy" src="https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/patent-iStock-466732957-1200x630-72dpi-1024x538.jpg" alt="" class="wp-image-1204" width="452" height="237" srcset="https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/patent-iStock-466732957-1200x630-72dpi-1024x538.jpg 1024w, https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/patent-iStock-466732957-1200x630-72dpi-300x158.jpg 300w, https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/patent-iStock-466732957-1200x630-72dpi.jpg 1200w" sizes="(max-width: 452px) 100vw, 452px" /></figure>



Earlier this month, on September 16, 2020, the Transitional Program for Covered Business Method (CBM) Review expired.<a href="#_ftn1" name="_ftnref1">[1]</a> Enacted as part of the AIA and spanning eight years, CBM Review was promoted within Congress as a vehicle to challenge weak patents, i.e., patents that should not have been issued in view of the Supreme Court’s Bilski decision and, later, its Alice decision.<a href="#_ftn2" name="_ftnref2">[2]</a> CBM Review was limited in duration and scope, and applied only to “covered business method[s]” while excepting “technological inventions.” In supporting those goals, CBM Review was utilized primarily within the financial industry, and permitted entities to challenge patents based on patent eligibility, unlike other post-grant tools that permitted only challenges based on prior art, such as ex parte reexamination and inter partes review (IPR).



CBM Review filings reached peak usage several years after being enacted. 



<figure class="wp-block-image alignright size-large"><img decoding="async" loading="lazy" width="1024" height="303" src="https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/IP-Image-chart-1-1024x303.png" alt="" class="wp-image-1203" srcset="https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/IP-Image-chart-1-1024x303.png 1024w, https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/IP-Image-chart-1-300x89.png 300w, https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/IP-Image-chart-1.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



A surge of filings was driven by an astronomically high invalidation rate at the Patent Trial and Appeal Board (PTAB), which was over 94% as of January 2015.<a href="#_ftn3" name="_ftnref3">[3]</a> In recent years, however, as the Federal Circuit narrowed the PTAB’s jurisdiction over CBM Review, parties filed far fewer CBM Review petitions than in earlier years.



Source: Docket Navigator as of September 23, 2020



And as compared to other review tools, CBM Reviews were used only minimally.



<figure class="wp-block-image aligncenter size-full"><img decoding="async" loading="lazy" width="682" height="369" src="https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/IP-Image-round-2-682x369-1.png" alt="" class="wp-image-1205" srcset="https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/IP-Image-round-2-682x369-1.png 682w, https://admin.ipintelligencereport.com/wp-content/uploads/sites/10/2023/07/IP-Image-round-2-682x369-1-300x162.png 300w" sizes="(max-width: 682px) 100vw, 682px" /></figure>



Source: USPTO, Trial Statistics IPR, PGR, CBM (January 2020), https://www.uspto.gov/sites/default/files/documents/trial_statistics_20200131.pdf



In view of the program’s sunset, some groups advocated for an extension of CBM Review and even argued for it to be made permanent. The Quality Patents Coalition, a consortium of retailers, banks, and others in the financial and service industries, advocated in a letter to Senator Richard Blumenthal and Senator David Perdue that the program should be extended to prevent a future “avalanche of meritless litigation.”<a href="#_ftn4" name="_ftnref4">[4]</a>



On the other hand, groups representing patent owners, such as the Licensing Executives Society (LES) and the Institute of Electrical and Electronics Engineers (IEEE), advocated for the expiration of CBM Review. A letter from the IEEE to Senator Thom Tillis and Senator Chris Coons cited CBM Review as “potent in decimating patent rights without the protections available in Article III courts.”<a href="#_ftn5" name="_ftnref5">[5]</a>



Director Andrei Iancu of the United States Patent and Trademark Office (USPTO) sides with patent owners. In a September 15, 2020, moderated event, he noted that CBM Review is “not a very popular program,” citing that around a dozen CBM Review petitions, compared with more than 1,000 IPR petitions, were filed in 2020.<a href="#_ftn6" name="_ftnref6">[6]</a> Further, Director Iancu characterized CBM Review as “inherently problematic in that it isolates a particular area of technology. And as we’ve been discussing throughout . . . as a general principal, it’s not good and it’s not in the tradition of the American patent system to isolate for whatever purpose a particular area of technology. So it should be allowed to sunset. It’s been the PTO’s long-standing position that it should sunset; even the prior administration issued a public statement that it should be allowed to sunset.”<a href="#_ftn7" name="_ftnref7">[7]</a>



For now, this is exactly what has happened, with no sign of resurrection for the time being.



<a href="#_ftnref1" name="_ftn1">[1]</a> Leahy-Smith America Invents Act, Pub. L. No. 112-29 § 18, 125 Stat. 284, 329-31 (2011) (AIA).



<a href="#_ftnref2" name="_ftn2">[2]</a> Bilski v. Kappos, 561 U.S. 593 (2010); Alice Corp. Pty. v. CLS Bank Int’l, 573 U.S. 208 (2014).



<a href="#_ftnref3" name="_ftn3">[3]</a> Gregory Dolin & Irina D. Manta, Taking Patents, 73 Wash. & Lee L. Rev. 719, 756 & n.230 (2016).



<a href="#_ftnref4" name="_ftn4">[4]</a> Letter from the Quality Patents Coalition to Senator David Perdue, and Senator Richard Blumenthal (Sept. 8, 2020).



<a href="#_ftnref5" name="_ftn5">[5]</a> Letter from James M. Conrad, President, IEEE-USA, to Senator Thom Tillis, Chairman, Subcommittee on Intellectual Property, and Senator Chris Coons, Ranking Member, Subcommittee on Intellectual Property (July 14, 2020).



<a href="#_ftnref6" name="_ftn6">[6]</a> Hudson Institute, A Conversation with USPTO Director Andrei Iancu on the Patent System and the Innovation Economy, YouTube (Sept. 15, 2020), https://www.hudson.org/events/preview/1857-video-event-a-conversation-with-uspto-director-andrei-iancu-on-the-patent-system-and-the-innovation-economy92020, at 59:06.



<a href="#_ftnref7" name="_ftn7">[7]</a> Id. at 59:37.

The Sun Has Set on CBM Review

Featured Insights

Related Services

Featured Insights